Citation : 2014 Latest Caselaw 5048 Del
Judgement Date : 10 October, 2014
* IN THE HIGH COURT OF DELHI AT NEW DELHI
Pronounced on: 10th October, 2014
+ CS(OS) 2067/2011
MERCK KGAA AND ONE ANOTHER ..... Plaintiffs
Through: Mr. Subhash Bhutoria, Advocate with
Mr. Anuj Nair, Advocate
versus
HASMUKH N THAKKAR ..... Defendant
Through: Ex-parte
CORAM:
HON'BLE MR. JUSTICE G.P. MITTAL
G.P. MITTAL,J.
1. This suit for permanent injunction restraining infringement of trade
mark and rendition of accounts, damages and delivery up, etc. was
filed by the Plaintiffs against the Defendant with the following
prayers:-
"a. A decree for permanent injunction restraining the Defendant's, by himself, his servants, agents etc. From manufacturing, selling, offering for sale, advertising directly or indirectly dealing in pharmaceutical and medicinal preparations under the trade mark ECEFLAM+ or any other trade mark deceptively and/or confusingly similar to the registered trademarks EXFLAM of the Plaintiff under Trade Mark Registration no.471455 and EMFLAM under registration no.4675968.
b. A decree for delivery of all the infringing goods as
complained of herein above, all blocks, dies and all such articles employed by Defendants in applying the trade mark EXEFLAM+ to the offending goods to an authorized representative of the Plaintiff for destructions/erasure.
c. An order for rendition of accounts of profit illegally earned by the Defendant and a decree for an amount so found due to in the alternative, a decree of Rs.20,05,000/- towards damages including conversion damages may be passed in favour of the Plaintiff and against the Defendant."
2. As per the averments made in the Plaint, Plaintiff no.1 is a reputed
pharmaceutical company established in the passed over 300 years and
is engaged in manufacture and marketing of wide range of
pharmaceutical preparations.
3. Plaintiff no.2 is its Indian subsidiary. It is averred that the Plaintiff
no.1 is the registered proprietor of the trademark EMFLAM under
registration no. 467598 dated 13.02.1987 in respect of the
pharmaceutical and medicinal preparation.
4. Plaintiff no.1 is also the registered proprietor of trademark EXFLAM
under registration no. 471455 dated 28.04.1987 in respect of the
pharmaceutical preparation under the provisions of the Trade Marks
Act, 1999. Plaintiff no.2 has significant sale of its pharmaceutical
preparation EXFLAM and EMFLAM as stated in para 11 of the plaint.
5. According to the Plaintiffs sometime in August, 2010, the Plaintiff
no.1 came to know that the Defendant has adopted the trademark
ECEFLAM+ in respect of his pharmaceutical and medicinal
preparations and so as to create an impression amongst the purchasing
public and trade that the product of the Defendant actually originates
from the Plaintiffs or there is some kind of association and/or nexus
between the Plaintiffs and the Defendant company.
6. Thus, the Plaintiffs filed a suit with the prayers as stated earlier.
7. The Defendant preferred not to contest the suit despite service through
publication and was thus, ordered to be proceeded ex-parte. In ex-
parte evidence, the Plaintiffs filed an Affidavit of Mr. Vijay Kumar
Verma and an Affidavit of Mr. Vishal Khat, who corroborated the
averments made in the Plaint and testified that the trademark
ECEFLAM+ has been used and adopted by the Defendant which is
deceptively and confusingly similar to the registered trade mark
EXFLAM and EMFLAM of the Plaintiffs.
8. I have heard learned counsel for the Plaintiffs.
9. It is well settled that while considering whether a mark is likely to
deceive or to cause confusion the question has to be approached from
the point of view of a man of average intelligence and imperfect
recollection. In Amritdhara Pharmacy v. Satya Deo Gupta, AIR 1963
SC 449, while referring to Corn Products Refining Co. v. Skangrila
Food Products Ltd., (1960) (1) SCR 968 ,in paras 7 and 8, the
Supreme Court held as under:-
"7. .......... As we said in Corn Products Refining Co. v. Skangrila Food Products Ltd. [ (1960) (1) SCR 968] the question has to be approached from the point of view of a man of average intelligence and imperfect recollection. To such a man the overall structural and phonetic similarity-of the two names "Amritdhara" and "Lakshmandhara" is, in our opinion, likely to deceive or cause confusion. We must consider the overall similarity of the two composite words "Amritdhara" and "Lakshmandhara". We do not think that the learned Judges of the High Court were right in saying that no Indian would mistake one for the other. An unwary purchaser of average intelligence and imperfect recollection would not, as the High Court supposed, split the name into its component parts and consider the etymological meaning thereof or even consider the meaning of the composite words as "current of nectar" or "current of Lakshman". He would go more by the overall structural and phonetic similarity and the nature of the medicine he has previously purchased, or has been told about, or about which has otherwise learnt and which he wants to purchase. Where the trade relates to goods largely sold to illiterate or badly educated persons, it is no answer to say that a person educated in the Hindi language would go by the etymological or ideological meaning and see the difference between "current of nectar" and "current of Lakshman". "Current of Lakshman" in a literal sense has no meaning; to give it meaning one must further make the inference that the "current or stream" is as pure and strong as Lakshman of the Ramayana. An ordinary Indian villager or townsman will perhaps know Lakshman, the story of the Ramayana being familiar to him; but we
doubt if he would etymologise to the extent of seeing the so- called ideological difference between "Amritdhara" and "Lakshmandhara". He would go more by the similarity of the two names in the context of the widely known medicinal preparation which he wants for his ailments.
8. We agree that the use of the word "dhara" which literally means "current or stream" is not by itself decisive of the matter. What we have to consider here is the overall similarity of the composite words, having regard to the circumstance that the goods bearing the two names are medicinal preparations of the same description. We are aware that the admission of a mark is not to be refused, because unusually stupid people, "fools or idiots", may be deceived. A critical comparison of the two names may disclose some points of difference, but an unwary purchaser of average intelligence and imperfect recollection would be deceived by the overall similarity of the two names having regard to the nature of the medicine he is looking for with a somewhat vague recollection that he had purchased a similar medicine on a previous occasion with a similar name......."
10. In Cadila Health Care Ltd. v. Cadila Pharmaceuticals Ltd., 2001 (5)
SCC 73, the Supreme Court after considering a large number of
judgments of Foreign Courts and Indian Courts cautioned that strict
measures to prevent confusion and lesser degree of proof is required
for a Plaintiff to prove infringement in pharmaceutical cases if the
marks are similar. In para 35, the Supreme Court observed as under:-
"35. Broadly stated, in an action for passing-off on the basis of unregistered trade mark generally for deciding the question of deceptive similarity the following factors are to be considered:
(a) The nature of the marks i.e. whether the marks are word marks or label marks or composite marks i.e. both words and label works.
(b) The degree of resembleness between the marks, phonetically similar and hence similar in idea.
(c) The nature of the goods in respect of which they are used as trade marks.
(d) The similarity in the nature, character and performance of the goods of the rival traders.
(e) The class of purchasers who are likely to buy the goods bearing the marks they require, on their education and intelligence and a degree of care they are likely to exercise in purchasing and/or using the goods.
(f) The mode of purchasing the goods or placing orders for the goods.
(g) Any other surrounding circumstances which may be relevant in the extent of dissimilarity between the competing marks."
11. In the instant case, the Defendant's mark in respect of his medicinal
preparation ECEFLAM+ is phonetically and visibly similar to the two
registered trademarks of the Plaintiffs, i.e., EMFLAM and EXFLAM.
12. It is, therefore, evident that the Defendant is infringing the registered
trademarks of the Plaintiffs and he is also passing off his goods as
those of the Plaintiffs.
13. The suit of the Plaintiffs is accordingly decreed in terms of prayers 'a'
and 'b' of the prayer clause in the plaint with cost.
14. At the time of hearing, the reliefs of damages and rendition of
accounts were given up by the learned counsel for the Plaintiffs.
15. The suit of the Plaintiffs is decreed in above terms.
16. Pending applications also stand disposed of.
17. Decree sheet be drawn accordingly.
(G.P. MITTAL) JUDGE OCTOBER 10, 2014 vk
Publish Your Article
Campus Ambassador
Media Partner
Campus Buzz
LatestLaws.com presents: Lexidem Offline Internship Program, 2026
LatestLaws.com presents 'Lexidem Online Internship, 2026', Apply Now!